Impact of elexacaftor/tezacaftor/ivacaftor on fat-soluble vitamin levels in children with cystic fibrosis.

Schembri, L; Warraich, S; Bentley, S; Carr, S B; Balfour-Lynn, I M

Schembri, L; Warraich, S; Bentley, S; Carr, S B; Balfour-Lynn, I M.

Affiliation

Schembri L; Department of Paediatric Dietetics, Royal Brompton Hospital, London, UK.
Warraich S; Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK.
Bentley S; Department of Paediatric Pharmacy, Royal Brompton Hospital, London, UK.
Carr SB; Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK.
Balfour-Lynn IM; Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK. Electronic address: i.balfourlynn@ic.ac.uk.

J Cyst Fibros ; 22(5): 843-846, 2023 Sep.

Article de En | MEDLINE | ID: mdl-37142523

Sujet(s)
Mots clés

CFTR modulators; Cystic fibrosis; Vitamins

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Rétinol / Mucoviscidose Limites: Child / Humans Langue: En Journal: J Cyst Fibros Année: 2023 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google